Sharon Bio-Medicine Ltd said its formulation plant at Dehradun has been approved by UK-based Medicines and Health Care Product Regulatory Agency (MHRA).
The company, located in Raigad, Maharashtra, expect the sales to start in near future to the UK and Europe, Sharon Bio-Medicine said in a regulatory filing.
On Friday, Sharon Bio-Medicine shares closed 3.2% higher at Rs135 on the Bombay Stock Exchange, while the Sensex ended at 1% up at 17,833 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
